SS Innovations International (NASDAQ:SSII) Trading 14.1% Higher After Insider Buying Activity

Shares of SS Innovations International, Inc. (NASDAQ:SSII) rose 14.1% during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as high as $5.10 and last traded at $5.0450. Approximately 53,240 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 99,295 shares. The stock had previously closed at $4.42.

Specifically, CEO Srivastava Sudhir acquired 498,753 shares of the stock in a transaction on Friday, March 6th. The shares were bought at an average price of $4.01 per share, with a total value of $1,999,999.53. Following the acquisition, the chief executive officer owned 109,851,767 shares of the company’s stock, valued at $440,505,585.67. This trade represents a 0.46% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy P. Adams bought 300,000 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were acquired at an average cost of $3.99 per share, with a total value of $1,197,000.00. Following the completion of the purchase, the director owned 5,331,902 shares in the company, valued at approximately $21,274,288.98. This represents a 5.96% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In other SS Innovations International news, Director Frederic H. Moll acquired 501,253 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The shares were purchased at an average price of $3.99 per share, with a total value of $1,999,999.47. Following the completion of the acquisition, the director directly owned 10,775,485 shares of the company’s stock, valued at approximately $42,994,185.15. The trade was a 4.88% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of SS Innovations International in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Key Headlines Impacting SS Innovations International

Here are the key news stories impacting SS Innovations International this week:

• Positive Sentiment: CEO Srivastava purchased 498,753 shares (~$2.0M at ~$4.01), a meaningful insider buy that signals management confidence. SEC filing: Srivastava purchase
• Positive Sentiment: Director Timothy P. Adams bought 300,000 shares (~$1.2M at $3.99), increasing his stake — reinforces insider support. SEC filing: Adams purchase
• Positive Sentiment: Vice‑Chair Dr. Frederic H. Moll acquired 501,253 shares (~$2.0M at $3.99), adding to insider participation. SEC filing: Moll purchase
• Positive Sentiment: Company released Q4 and full‑year 2025 results showing strong growth in SSi Mantra installations, procedures and revenue — supports the growth narrative for device adoption. GlobeNewswire: Q4/FY2025 results
• Positive Sentiment: SS Innovations completed an $18.6M private placement to fund U.S./EU expansion and working capital — provides near‑term cash to support commercialization efforts. GlobeNewswire: Private placement
• Neutral Sentiment: Some institutional investors have added positions recently, which could support liquidity and longer‑term demand but may not alter near‑term volatility. QuiverQuant: ownership/placement summary
• Negative Sentiment: Company reported a small quarterly loss (EPS $(0.01)) with a negative net margin (~‑32.1%) and negative ROE (~‑34.1%), underscoring that profitability is still distant. MarketBeat: earnings summary
• Negative Sentiment: The private placement issued ~5.77M new shares and included unregistered securities/warrants to a FINRA firm — this raises dilution and registration/liquidity concerns. GlobeNewswire: private placement terms
• Negative Sentiment: Regulatory timing (FDA 510(k) review expected mid‑2026 and CE efforts) creates execution risk; outcomes and timing will strongly affect the share path. GlobeNewswire: regulatory timeline
• Negative Sentiment: Analyst coverage is limited and includes a recent Sell (Weiss Ratings) — a reminder of continued skepticism among some research shops. Weiss Ratings: research note

SS Innovations International Stock Up 15.0%

The stock’s fifty day simple moving average is $4.82 and its 200-day simple moving average is $6.05. The company has a market capitalization of $988.32 million and a PE ratio of -101.70.

SS Innovations International (NASDAQ:SSII) last announced its quarterly earnings results on Tuesday, March 10th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative return on equity of 34.13% and a negative net margin of 32.10%.The firm had revenue of $14.53 million for the quarter.

Institutional Trading of SS Innovations International

Institutional investors have recently bought and sold shares of the company. PNC Financial Services Group Inc. grew its holdings in SS Innovations International by 58.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 13,627 shares of the company’s stock valued at $77,000 after purchasing an additional 5,000 shares during the last quarter. Handelsbanken Fonder AB boosted its position in shares of SS Innovations International by 9.3% in the 4th quarter. Handelsbanken Fonder AB now owns 120,000 shares of the company’s stock worth $682,000 after buying an additional 10,198 shares in the last quarter. Envestnet Asset Management Inc. acquired a new stake in SS Innovations International in the 3rd quarter valued at about $71,000. Jane Street Group LLC acquired a new stake in SS Innovations International in the 4th quarter valued at about $63,000. Finally, IFC & Insurance Marketing Inc. acquired a new position in SS Innovations International during the fourth quarter worth about $64,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.